Kubota Pharmaceutical Holdings
4596.TTSE GROWTHPharmaceutical
Financials · Consolidated
| Fiscal year ended | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|---|
| Revenue | ¥21m | ¥27m | ¥40m | ¥8m | — | ¥38m |
| Operating income | −¥895m | −¥1.3bn | −¥1.5bn | −¥2.0bn | −¥2.6bn | — |
| Net income (owners) | −¥676m | −¥1.3bn | −¥1.5bn | −¥2.0bn | −¥2.6bn | −¥2.4bn |
| Total assets | ¥2.0bn | ¥1.5bn | ¥3.0bn | ¥4.4bn | ¥4.8bn | ¥6.7bn |
| Net assets / equity | ¥1.8bn | ¥1.4bn | ¥2.6bn | ¥3.9bn | ¥4.2bn | ¥6.0bn |
| Operating cash flow | −¥583m | −¥1.2bn | −¥1.3bn | −¥2.1bn | −¥2.5bn | −¥2.2bn |
| EPS (basic) | ¥-10.59 | ¥-23.65 | ¥-26.79 | ¥-40.92 | ¥-57.46 | ¥-56.9 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 3
| Period | Form | Figures |
|---|---|---|
| 2026-01-01 → 2026-06-30 | Half-year | 80 figures · EDINET |
| 2025-01-01 → 2025-06-30 | Half-year | 78 figures · EDINET |
| 2024-01-01 → 2024-06-30 | Half-year | 92 figures · EDINET |
25 more reports are still being processed.